← Browse by Condition
Medical Condition
preeclampsia
Total Trials
12
Recruiting Now
12
Trial Phases
Phase 1, Phase 4
ClinicalMetric tracks all active clinical trials for preeclampsia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — preeclampsia Clinical Trials
How many clinical trials are currently recruiting for preeclampsia?
ClinicalMetric currently tracks 12 actively recruiting clinical trials for preeclampsia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for preeclampsia?
preeclampsia research spans Phase 1 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a preeclampsia clinical trial?
Eligibility criteria for preeclampsia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06858345
Recruiting
Enrollment
50 pts
Location
Spain
Sponsor
Fundacion para la Formacion e ...
NCT07282171 Phase 1
Recruiting
Enrollment
60 pts
Location
Australia
Sponsor
Comanche Biopharma
NCT06953115
Recruiting
Enrollment
210 pts
Location
Mexico
Sponsor
Fundación Internacional René M...
NCT05445544
Recruiting
Enrollment
10,000 pts
Location
China
Sponsor
Zhujiang Hospital
NCT07084727
Recruiting
Enrollment
60 pts
Location
Belgium
Sponsor
University Hospital, Antwerp
NCT06962644
Recruiting
Enrollment
160 pts
Location
Pakistan
Sponsor
Pakistan Air Force (PAF) Hospi...
NCT05676476
Recruiting
Enrollment
132 pts
Location
United States
Sponsor
University of Alabama at Birmi...
NCT06632379 Phase 4
Recruiting
Enrollment
76 pts
Location
United States
Sponsor
Ohio State University
NCT05786235
Recruiting
Enrollment
60 pts
Location
Italy
Sponsor
IRCCS San Raffaele
NCT06464159
Recruiting
Enrollment
100 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT07229261
Recruiting
Enrollment
80 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT06918236
Recruiting
Enrollment
12,084 pts
Location
Bulgaria, Greece, Sp...
Sponsor
Aristotle University Of Thessa...
Related Conditions
gestational hypertension (3) sflt1 mediated preterm preeclampsia (1) preterm preeclampsia (1) microbiome (1) endothelial function fmd (1) retinal vessels (1) urinary tract infection diagnosis (1) hypertensive disorder of pregnancy (1) hypertensive disorders of pregnancy (1) immunologic disease (1) antiphospholipid antibody syndrome primary (1) pregnancy complications (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology